Total Payments
$58,192
2024 Payments
$115.91
Companies
9
Transactions
61
Payment Breakdown by Category
Other$54,683 (94.0%)
Travel$2,185 (3.8%)
Food & Beverage$1,324 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $54,683 | 25 | 94.0% |
| Travel and Lodging | $2,185 | 7 | 3.8% |
| Food and Beverage | $1,324 | 29 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neos Therapeutics, LP | $50,382 | 31 | $0 (2018) |
| Supernus Pharmaceuticals, Inc. | $7,254 | 13 | $0 (2021) |
| ITI, Inc. | $124.19 | 1 | $0 (2022) |
| IDORSIA PHARMACEUTICALS US INC | $115.91 | 1 | $0 (2024) |
| Shire North American Group Inc | $115.65 | 10 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $84.28 | 1 | $0 (2023) |
| ABBVIE INC. | $52.90 | 2 | $0 (2022) |
| Tris Pharma Inc | $38.22 | 1 | $0 (2023) |
| Alkermes, Inc. | $24.40 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.91 | 1 | IDORSIA PHARMACEUTICALS US INC ($115.91) |
| 2023 | $122.50 | 2 | Janssen Pharmaceuticals, Inc ($84.28) |
| 2022 | $201.49 | 4 | ITI, Inc. ($124.19) |
| 2021 | $2,651 | 4 | Supernus Pharmaceuticals, Inc. ($2,651) |
| 2018 | $27,272 | 20 | Neos Therapeutics, LP ($22,669) |
| 2017 | $27,828 | 30 | Neos Therapeutics, LP ($27,713) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/20/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $115.91 | General |
| Category: Insomnia | ||||||
| 07/05/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $38.22 | General |
| Category: ADHD | ||||||
| 03/28/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $84.28 | General |
| Category: Neuroscience | ||||||
| 09/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.29 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: CNS | ||||||
| 08/02/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.19 | General |
| Category: PSYCHIATRY | ||||||
| 04/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2021 | Supernus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 03/25/2021 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.71 | General |
| 02/26/2021 | Supernus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| 02/26/2021 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.36 | General |
| 11/16/2018 | Supernus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| 11/16/2018 | Supernus Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $481.40 | General |
| 11/16/2018 | Supernus Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $350.00 | General |
| 11/16/2018 | Supernus Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $309.05 | General |
| 11/16/2018 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $93.55 | General |
| 11/16/2018 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $68.01 | General |
| 11/16/2018 | Supernus Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $67.44 | General |
| 11/16/2018 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $54.41 | General |
| 11/15/2018 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $179.47 | General |
| 09/11/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,625.00 | General |
| Category: ADHD | ||||||
| 08/28/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: ADHD | ||||||
| 08/28/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,625.00 | General |
| Category: ADHD | ||||||
| 07/03/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: ADHD | ||||||
| 06/26/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: ADHD | ||||||
About Dr. William Dodson, M.D
Dr. William Dodson, M.D is a Prescribing (Medical) healthcare provider based in Greenwood Village, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1922278027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Dodson, M.D has received a total of $58,192 in payments from pharmaceutical and medical device companies, with $115.91 received in 2024. These payments were reported across 61 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($54,683).
Ad
Practice Information
- Specialty Prescribing (Medical)
- Location Greenwood Village, CO
- Active Since 03/04/2008
- Last Updated 03/04/2008
- Taxonomy Code 103TP0016X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922278027
Products in Payments
- Adzenys XR-ODT (Drug) $50,382
- CAPLYTA (Drug) $124.19
- QUVIVIQ (Drug) $115.91
- SPRAVATO (Drug) $84.28
- MYDAYIS (Drug) $61.94
- VYVANSE (Drug) $53.71
- VRAYLAR (Drug) $52.90
- Dyanavel XR (Drug) $38.22
- ARISTADA (Drug) $24.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.